Search Results - "Mika Iwakura"

  • Showing 1 - 5 results of 5
Refine Results
  1. 1
    Safety and effectiveness, including intelligence prognosis, of diazoxide in pediatric patients with hyperinsulinemic hypoglycemia: special survey in Japan (long-term, all-case survey)

    Safety and effectiveness, including intelligence prognosis, of diazoxide in pediatric patients with hyperinsulinemic hypoglycemia: special survey in Japan (long-term, all-case survey) by Fukutomi, Miwa, Shimodera, Minoru, Maeda, Yoshikazu, Iwakura, Mika, Hara, Mitsuyoshi

    Published in Clinical Pediatric Endocrinology (01-01-2018)
    “…To evaluate the safety and effectiveness of the long-term administration of diazoxide in patients with hyperinsulinemic hypoglycemia, a post-marketing…”
    Get full text
    Journal Article
    Save to List
    Saved in:
  2. 2
    Suvorexant (Belsomra® Tablets 10, 15, and 20 mg): Japanese Drug-Use Results Survey

    Suvorexant (Belsomra® Tablets 10, 15, and 20 mg): Japanese Drug-Use Results Survey by Asai, Yuko, Sano, Hideki, Miyazaki, Makoto, Iwakura, Mika, Maeda, Yoshikazu, Hara, Mitsuyoshi

    Published in Drugs in R&D (01-03-2019)
    “…Background We report on the results of a Japanese postmarketing drug-use survey of suvorexant (Belsomra ® ) tablets. Methods A survey with a ≤ 6-month…”
    Get full text
    Journal Article
    Save to List
    Saved in:
  3. 3
    Safety and effectiveness, including intelligence prognosis, of diazoxide in pediatric patients with hyperinsulinemic hypoglycemia : special survey in Japan (long-term, all-case survey)

    Safety and effectiveness, including intelligence prognosis, of diazoxide in pediatric patients with hyperinsulinemic hypoglycemia : special survey in Japan (long-term, all-case survey) by Miwa Fukutomi, Minoru Shimodera, Yoshikazu Maeda, Mika Iwakura, Mitsuyoshi Hara

    Published in Clinical Pediatric Endocrinology (01-07-2018)
    “…Abstract. To evaluate the safety and effectiveness of the long-term administration of diazoxide in patients with hyperinsulinemic hypoglycemia, a…”
    Get full text
    Journal Article
    Save to List
    Saved in:
  4. 4
    Real-world evidence of the safety and efficacy profile of suvorexant in elderly patients with insomnia: a sub-analysis of the post-marketing drug-use results survey in Japan

    Real-world evidence of the safety and efficacy profile of suvorexant in elderly patients with insomnia: a sub-analysis of the post-marketing drug-use results survey in Japan by Takeuchi, Yuko, Sano, Hideki, Asai, Yuko, Miyazaki, Makoto, Iwakura, Mika, Maeda, Yoshikazu

    Published in Current medical research and opinion (03-03-2020)
    “…Objective: Global Phase III trials of suvorexant showed no obvious differences in the safety and efficacy profile of suvorexant between elderly and non-elderly…”
    Get full text
    Journal Article
    Save to List
    Saved in:
  5. 5
    Long-Term Safety and Efficacy of Sitagliptin for Type 2 Diabetes Mellitus in Japan: Results of a Multicentre, Open-Label, Observational Post-Marketing Surveillance Study

    Long-Term Safety and Efficacy of Sitagliptin for Type 2 Diabetes Mellitus in Japan: Results of a Multicentre, Open-Label, Observational Post-Marketing Surveillance Study by Yoshikawa, Ken, Tsuchiya, Akira, Kido, Tomoyuki, Ota, Tomohiro, Ikeda, Keiko, Iwakura, Mika, Maeda, Yoshikazu, Maekawa, Shinichiroh

    Published in Advances in therapy (01-05-2020)
    “…Introduction A post-marketing surveillance (PMS) study was conducted to confirm the long-term risk–benefit profile of sitagliptin administered to Japanese…”
    Get full text
    Journal Article
    Save to List
    Saved in:

Search Tools: